Skip to main content
. Author manuscript; available in PMC: 2017 Aug 17.
Published in final edited form as: Osteoporos Int. 2016 Jun 24;27(12):3485–3494. doi: 10.1007/s00198-016-3675-7

Table 2. Prediction of accelerated vBMD loss (defined as being in the upper quartile of annual % bone loss) of femoral neck and total hip by BTM in women.

vBMD loss Model CTX OC PINP



OR 95% CI OR 95% CI OR 95% CI
Femoral neck
 Trabecular (-14.3 to 3.4 %) 1 1.44 0.94-2.20 1.94 1.27-2.96 1.35 0.89-2.06
2 1.49 0.94-2.34 2.30 1.44-3.70 1.45 0.92-2.28
 Cortical (-6.5 to -0.4 %) 1 1.98 1.31-2.99 2.44 1.61-3.70 2.08 1.38-3.13
2 1.76 1.13-2.75 2.20 1.39-3.48 1.89 1.22-2.92
Total hip
 Trabecular (-7.6 to -2.5 %) 1 1.16 0.75-1.80 1.73 1.13-2.66 1.52 1.00-2.32
2 1.23 0.77-1.97 2.02 1.25-3.27 1.71 1.09-2.69
 Cortical (-3.6 to -0.4 %) 1 1.70 1.12-2.59 2.00 1.31-3.04 1.63 1.08-2.47
2 1.57 1.01-2.47 1.94 1.22-3.08 1.48 0.95-2.30

Data are presented as odds ratios (95% CI) and are bold if p< 0.05 for the highest quartile of BTM levels (CTX ≥0.50, OC ≥31.80, and PINP ≥47.95) calculated by logistic regression; Model 1 - adjusted for age; Model 2 - adjusted for age, BMI, smoking, alcohol consumption, physical activity level, mobility disability, serum 25OHD, PTH, follow-up duration, DM, Oral glucocorticoid or antiepileptic drugs, anti-bone loss drugs, and age at menopause.